DaVita Inc. (NYSE:DVA) Receives $157.00 Average PT from Analysts

DaVita Inc. (NYSE:DVA) has been given an average rating of “Hold” by the five brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $157.00.

A number of research firms have issued reports on DVA. StockNews.com cut shares of DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. Truist Financial raised their price target on shares of DaVita from $150.00 to $165.00 and gave the stock a “hold” rating in a report on Tuesday, August 20th. UBS Group increased their price objective on shares of DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. TD Cowen increased their price objective on shares of DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research note on Wednesday, July 24th. Finally, Bank of America increased their price objective on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 7th.

Insider Activity at DaVita

In related news, COO Michael David Staffieri sold 9,539 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the sale, the chief operating officer now owns 241,945 shares in the company, valued at $36,299,008.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the transaction, the insider now directly owns 83,011 shares of the company’s stock, valued at $12,137,038.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Michael David Staffieri sold 9,539 shares of the stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the transaction, the chief operating officer now directly owns 241,945 shares in the company, valued at $36,299,008.35. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 173,482 shares of company stock worth $27,387,069. 2.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On DaVita

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Blue Trust Inc. lifted its stake in shares of DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after buying an additional 78 shares in the last quarter. Newbridge Financial Services Group Inc. acquired a new position in shares of DaVita in the fourth quarter valued at approximately $30,000. Principal Securities Inc. acquired a new position in shares of DaVita in the fourth quarter valued at approximately $37,000. Family Firm Inc. acquired a new position in shares of DaVita in the second quarter valued at approximately $43,000. Finally, Versant Capital Management Inc grew its holdings in DaVita by 90.6% during the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after acquiring an additional 155 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Trading Down 0.6 %

NYSE:DVA opened at $163.16 on Thursday. DaVita has a 52 week low of $71.51 and a 52 week high of $166.04. The firm has a 50 day moving average of $146.25 and a 200 day moving average of $140.54. The company has a quick ratio of 1.12, a current ratio of 1.16 and a debt-to-equity ratio of 9.94. The stock has a market capitalization of $14.31 billion, a price-to-earnings ratio of 18.54, a PEG ratio of 0.95 and a beta of 0.87.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.47 by $0.12. The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.15 billion. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The business’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the company posted $2.08 earnings per share. As a group, sell-side analysts anticipate that DaVita will post 9.99 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.